Five Story Walkup — With LaBute, Guare Works — Starts 13th Street Rep Benefit Run March 21 | Playbill

Related Articles
News Five Story Walkup — With LaBute, Guare Works — Starts 13th Street Rep Benefit Run March 21 Five Story Walkup, featuring new plays and monologues by John Guare, Neil LaBute and more, begins March 21 in New York City.

Daniel Gallant directs The Thirteenth Street Repertory Company presentation slated to run through April 14. The staging is billed as "a benefit production to save the Thirteenth Street Repertory Theatre." The 90-minute show plays 7 PM curtains.

The collection of works — which boasts the efforts of John Guare, Neil LaBute, Laura Shaine Cunningham, Quincy Long, Daniel Frederick Levin, Clay McLeod Chapman and Gallant himself — "follow the travails of mismatched lovers, a webcam provocateur, small-town philosophers and urban pioneers as they strive to maintain or escape from their domestic situations." They are "tied together by an intimate focus on the bond between identity and home."

The titles include Neil LaBute's Love at Twenty, Quincy Long's Aux Cops, Laura Shaine Cunningham's Web Cam Woman, Clay McLeod Chapman's Birdfeeder, Daniel F. Levin's Glorious Night and Daniel Gallant's Tripartite. The John Guare work is an untitled monologue.

Founded in 1972, The Thirteenth Street Repertory Theatre "is engaged in a struggle against real estate developers," according to a release. "The future of this historic arts organization is in danger, and the artists featured in Five Story Walkup have donated their time and effort to benefit the Thirteenth Street Rep's Legal Fund."

Thirteenth Street Rep is the longtime home to the long-running New York staging of Israel Horovitz's Line. The venue is located at 50 West 13th Street (between Fifth and Sixth Avenues) in downtown Manhattan. For tickets to Five Story Walkup at Thirteenth Street Rep, call (212) 352-3101 or visit

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!